A case of early morning abnormal behavior and refractory epilepsy
Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 10
Abstract
Insulinomas are rare neuroendocrine tumors of pancreatic islet cells that retain the ability to produce and secrete inappropriately high insulin. The clinical symptoms of insulinoma are the subsequent to development of hypoglycemia. We herein present a case of one patient who had been symptomatic for 6 years with symptoms of early morning abnormal behavior and refractory epilepsy, which eventually was diagnosed as a case of Insulinoma and could be cured after successful removal of lesion. All patients with unexplained abnormal behavior and seizure disorder should have blood glucose level checked during the episode.
Authors and Affiliations
Deepak Khandelwal, Deep Dutta, Joshita Gupta
Keywords
Related Articles
- EP ID EP616014
- DOI -
- Views 154
- Downloads 0
Rare case of familial restrictive cardiomyopathy : a case report
Familial restrictive cardiomyopathy is an extremely rare disease affecting the heart. The exact incidence and genetic associations are not well delineated. It generally presents with a restrictive filling pattern on echo...
Co-morbid conditions of infertile couples a community based study
Infertility is a public health problem affecting people worldwide from all the communities with various causes. In any society being a parent is as a normal assumption of adult life. The crisis of infertility makes the c...
Maternal Death Reviews : an analysis in a teaching hospital in North Bihar
A maternal death review (MDR) is a medical audit which goes beyond merely enumerating the causes of maternal deaths. It investigates the community and hospital circumstances due to which currently available life-saving i...
Short term outcome of conservative versus steroid injection in tennis elbow in eastern India population a randomized control study
Tennis Elbow is a common clinical entity.we have compared two different methods,conservative versus steroid injection for treating this condition.24 patients were studied and shown a better clinical outcome in injection...
Basal insulin and glucagon-like peptide 1 receptor agonist (GLP1-RA) combination
Diabetes mellitus is a chronic disease affecting more than 425 million people worldwide. Patients with type 2 diabetes frequently do not reach HbA1c targets. Historically insulin has been viewed as the most effective glu...